Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Healthy Directions, Llc for the product Instaflex Extra Strength Pain Relief Cream (NDC 70015-660). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - ask doctor, otc - when using, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Active Ingredients
Menthol (2.5%)
Methyl Salicylate (10%)
Purpose
Topical Analgesic
Uses Temporarily relieves minor aches and pains of muscles
and joints associated with:
Warnings
For external use only
Do not use
Ask a doctor before use if you have
redness over the affected area
When using this product
Stop use and ask a doctor if
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions Adults and children 12 years of
age and older: Apply to affected area no more than
3-4 times daily. Children under 12 years of age:
Consult a doctor.
Other Information Keep product at room termperature and
humidity [59-86°F (15-30°C), 40% RH]. Do not freeze. For Lot
Number and Expiration Date, see crimp at end of tube.
Inactive ingredients C13-14 Isoparaffin, Citrus Aurantium
Dulcis (Orange) Oil, Ethylhexlglycerin, Eucalyptus Globulus Oil,
Glyceryl Stearate, Laureth-7, Oxygenated Corn Oil, PEG-100
Stearate, Phenoxyethanol, Polyacrylamide, Polysorbate-20, Water
EXTRA STRENGTH PAIN RELIEVING CREAM
Instaflex
PAIN RELIEF
Formulated with an
EXCLUSIVE OXYGENATED OIL
FAST, EXTRA STRENGTH RELIEF FOR
ARTHRITIS, JOINT & MUSCLE PAIN
DOUBLE THE PAIN-FIGHTING INGREDIENTS
DOUBLE THE MENTHOL POWER*
Deep Penetrating | Fast Acting | Great for Nighttime Use
EXTRA STRENGTH | DOCTOR DEVELOPED
Net wt. [2/4] oz ([57/113] g)
* Please review the disclaimer below.